A federal judge in Brazil is under fire for approving gay “conversion therapy, ” across the nation. Waldema de Carvalho overturned a 1999 Federal Council of Psychology decision that banned the largely discredited practice, ruling last week in favor of an evangelical Christian psychologist whose license had been revoked after she offered treatments claiming to...
NYS Entity Status
NYS Filing Date
MARCH 11, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - CITYTOUCH - LICENSED MASSAGE THERAPY PLLC
Around the Web
- Judge in Brazil approves gay ‘conversion therapy’
By Tamar Lapin - Wednesday Sep 20, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Ex-Florida QB gives up teaching license after allegedly asking student to touch his penis
By David K. Li - Friday Oct 20, 2017
A former University of Florida quarterback lost his teaching gig after asking an under-aged female student to inappropriately touch him, reports said. Chris Leak voluntary gave up his Florida Educator’s Certificate over accusations that he got a massage from a 15-year-old girl on Sept. 5, 2015 before asking her to touch his penis, according to...
- Mother-daughter duo busted in erotic massage parlor sting
By Jackie Salo - Friday Aug 18, 2017
A mother-daughter duo was busted earlier this week for an unlicensed massage parlor offering sexual favors. Anne Dodge, 55, and Jennifer Dodge, 30, were arrested after authorities received a tip alleging prostitution at their home in Sarasota, Florida. The pair posted ads to Backpage.com advertising their erotic services, news station WFTS reported. “I am a beautiful,...
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]